Enspryng?

See the DrugPatentWatch profile for Enspryng

What is Enspryng?

Enspryng is a cancer medicine. It’s an antibody-drug conjugate designed to deliver a chemotherapy-like payload directly to specific target cells in the body. [1]

What condition is Enspryng used for?

Enspryng is used in the treatment of non-small cell lung cancer (NSCLC). [1]

How is Enspryng given?

Enspryng is given by intravenous (IV) infusion. [1]

Who makes Enspryng, and what does its full name mean?

The brand name is Enspryng, and the active ingredient is mirvetuximab soravtansine. [1]

Is Enspryng a chemotherapy?

It is not traditional chemotherapy (like systemic IV cytotoxic drugs). Instead, it’s an antibody-drug conjugate that targets cancer cells and releases a cytotoxic agent inside them. [1]

---

Sources

[1] https://www.ensprynghcp.com/